PET-BT Use in Evaluation of Metastatic Ovarian Cancers

dc.contributor.authorKoroglu, Reyhan
dc.date.accessioned2024-08-04T21:00:09Z
dc.date.available2024-08-04T21:00:09Z
dc.date.issued2012
dc.departmentİnönü Üniversitesien_US
dc.description.abstractMany patients with ovarian cancer are at high risk of recurrence especially in the 2 years following fist-line therapy. CA 125 serum levels measurement associated to computed tomography (BT), ultrasound (US) and magnetic resonance imaging (MRI) are currently used during follow-up to detect recurrent disease. However, CT is the most effective and useful tool at all of these conventional methods. Unfortunately, in a relevant percentage of cases all of these traditional imaging techniques provide a significant number of doubtful/equivocal results or turn out negative even in presence of elevated Ca 125 levels. Noninvasive diagnosis of early recurrence of ovarian cancer is challenging due to the small size of peritoneal metastases. Occasionally small-volume disease may not be evident at anatomic imaging in patients with high CA 125 levels. Positron emission tomography (PET) can help of these patients to identify patients with recurrent tumor. Nevertheless, lesion localization for possible surgery is difficult with PET alone. Combined functional-anatomic imaging with fused PET and computed tomographic (CT) scans is practicable and may upgrade disease detection by increasing radiologic sensitivity and specificity.en_US
dc.identifier.endpage49en_US
dc.identifier.issn1309-3878
dc.identifier.issue1en_US
dc.identifier.startpage44en_US
dc.identifier.urihttps://hdl.handle.net/11616/103847
dc.identifier.volume4en_US
dc.identifier.wosWOS:000420937800012en_US
dc.identifier.wosqualityN/Aen_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.language.isotren_US
dc.publisherDuzce Univen_US
dc.relation.ispartofKonuralp Tip Dergisien_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectmetastatic over canceren_US
dc.subjectPET/CTen_US
dc.subjectCA 125en_US
dc.titlePET-BT Use in Evaluation of Metastatic Ovarian Cancersen_US
dc.typeArticleen_US

Dosyalar